A similar trend was found for FEV1 improvement on day 180 in moderate patients, although these did not reach statistical significance.
← all excerpts
Safety and efficacy of human umbilical cord-derived mesenchymal stem cells in COVID-19 patients: A real-world observation.
2
—
—
The sentences
In addition, a positive trend in the improvement of FEV1 on day 180 and DL CO on day 360 was observed in severe patients receiving MSC treatment.